These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
27. Prospective evaluation of [ Schwarzenböck SM; Eiber M; Kundt G; Retz M; Sakretz M; Kurth J; Treiber U; Nawroth R; Rummeny EJ; Gschwend JE; Schwaiger M; Thalgott M; Krause BJ Eur J Nucl Med Mol Imaging; 2016 Nov; 43(12):2105-2113. PubMed ID: 27317482 [TBL] [Abstract][Full Text] [Related]
28. Impact of enzalutamide administration on primary prostate cancer volume: a metabolic evaluation by choline positron emission tomography in castration-resistant prostate cancer patients. Caffo O; Maines F; Donner D; Veccia A; Chierichetti F; Galligioni E Clin Genitourin Cancer; 2014 Oct; 12(5):312-6. PubMed ID: 24806400 [TBL] [Abstract][Full Text] [Related]
29. von Eyben FE; Picchio M; von Eyben R; Rhee H; Bauman G Eur Urol Focus; 2018 Sep; 4(5):686-693. PubMed ID: 28753806 [TBL] [Abstract][Full Text] [Related]
30. Imaging of Prostate Cancer Using Castellucci P; Ceci F; Fanti S PET Clin; 2017 Apr; 12(2):137-143. PubMed ID: 28267448 [TBL] [Abstract][Full Text] [Related]
31. Histological verification of 11C-choline-positron emission/computed tomography-positive lymph nodes in patients with biochemical failure after treatment for localized prostate cancer. Schilling D; Schlemmer HP; Wagner PH; Böttcher P; Merseburger AS; Aschoff P; Bares R; Pfannenberg C; Ganswindt U; Corvin S; Stenzl A BJU Int; 2008 Aug; 102(4):446-51. PubMed ID: 18410442 [TBL] [Abstract][Full Text] [Related]
32. (18)F-Fluorocholine PET/CT for early response assessment in patients with metastatic castration-resistant prostate cancer treated with enzalutamide. De Giorgi U; Caroli P; Scarpi E; Conteduca V; Burgio SL; Menna C; Moretti A; Galassi R; Rossi L; Amadori D; Paganelli G; Matteucci F Eur J Nucl Med Mol Imaging; 2015 Jul; 42(8):1276-83. PubMed ID: 25808631 [TBL] [Abstract][Full Text] [Related]
33. Stereotactic Radiotherapy for Lesions Detected via Pan J; Wei Y; Zhang T; Liu C; Hu X; Zhao J; Gan H; Liu W; Zhu B; Wu J; Wang B; Song S; Ye D; Zhu Y Eur Urol Oncol; 2022 Aug; 5(4):420-427. PubMed ID: 35304107 [TBL] [Abstract][Full Text] [Related]
34. Therapeutic Algorithm Guided by Sequential 11C-Choline PET/CT in a Patient With Metastatic Castration-Resistant Prostate Cancer. Garcia Garzon JR; Bassa P; Soler M; Moragas M; Llinares E; Riera E Clin Nucl Med; 2015 Jul; 40(7):600-1. PubMed ID: 25742237 [TBL] [Abstract][Full Text] [Related]
35. Underestimation of Positron Emission Tomography/Computerized Tomography in Assessing Tumor Burden in Prostate Cancer Nodal Recurrence: Head-to-Head Comparison of Fossati N; Scarcella S; Gandaglia G; Suardi N; Robesti D; Boeri L; Karnes RJ; Heidenreich A; Pfister D; Kretschmer A; Buchner A; Stief C; Battaglia A; Joniau S; Van Poppel H; Osmonov D; Juenemann KP; Shariat S; Hiester A; Nini A; Albers P; Tilki D; Graefen M; Gill IS; Mottrie A; Galosi AB; Montorsi F; Briganti A J Urol; 2020 Aug; 204(2):296-302. PubMed ID: 32068488 [TBL] [Abstract][Full Text] [Related]
36. The relationship between local recurrences and distant metastases in prostate cancer: can Giovacchini G; Ciarmiello A; Giovannini E; Fodor A; Cozzarini C; Mapelli P; Incerti E; Di Muzio N; Gianolli L; Picchio M Eur J Nucl Med Mol Imaging; 2018 Jun; 45(6):962-969. PubMed ID: 29453702 [TBL] [Abstract][Full Text] [Related]
37. Assessment of the viability and treatment response of bone metastases in patients with metastatic castration-resistant prostate cancer using choline PET/CT. Kitajima K; Yamamoto S; Kawanaka Y; Komoto H; Shimatani K; Hanasaki T; Taguchi M; Nagasawa S; Yamada Y; Kanematsu A; Yamakado K Medicine (Baltimore); 2021 Jun; 100(23):e26206. PubMed ID: 34115004 [TBL] [Abstract][Full Text] [Related]
38. Prognostic and Theranostic Applications of Positron Emission Tomography for a Personalized Approach to Metastatic Castration-Resistant Prostate Cancer. Filippi L; Frantellizzi V; Chiaravalloti A; Pontico M; De Feo MS; Corica F; Montebello M; Schillaci O; De Vincentis G; Bagni O Int J Mol Sci; 2021 Mar; 22(6):. PubMed ID: 33809749 [TBL] [Abstract][Full Text] [Related]
39. Prognostic Value of [ Cysouw M; Bouman-Wammes E; Hoekstra O; van den Eertwegh A; Piet M; van Moorselaar J; Boellaard R; Dahele M; Oprea-Lager D Int J Radiat Oncol Biol Phys; 2018 Jun; 101(2):406-410. PubMed ID: 29559285 [TBL] [Abstract][Full Text] [Related]
40. A real-world evaluation of radium-223 in combination with abiraterone or enzalutamide for the treatment of metastatic castration-resistant prostate cancer. Kim SI; Szeto AH; Morgan KP; Brower B; Dunn MW; Khandani AH; Godley PA; Rose TL; Basch EM; Milowsky MI; Whang YE; Crona DJ PLoS One; 2021; 16(6):e0253021. PubMed ID: 34153052 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]